In this MedCity news article, Stephanie Baum synthesizes how Seeker Health helps pharma and biotech companies enroll their clinical trials faster. Seeker Health uses Digital Media (e.g. Facebook and Google Ads) in combination with our software and expert team to accelerate clinical trials for small to mid-sized pharma companies—especially those focused in rare and oncology.
Seeker Health, a digital health company innovating the way that people with serious diseases enroll in clinical trials, today announced the launch of the Seeker Portal™, the company's patent-pending clinical trial patient lead management software that helps evaluate, assign, manage and track participants to enrollment. Focused on the mantra that "Nothing Happens Without Patients™," Seeker Health is accelerating drug development by deploying compliant social media campaigns to improve patient education and using the Seeker Portal to accelerate the enrollment of participants into clinical studies for serious or rare diseases.
A clinical trial is the sole way that new medicines come to market. Mastering the process of finding, engaging, and activating patients for enrollment into a clinical trial is a key success factor for all biopharmaceutical companies developing new treatments, yet many companies often struggle to find the required clinical trial participants within a given timeline. Social media provide a level of efficient targeting that would rarely be accomplished by any other media. Click here to access this guide.
In this American Journal of Managed Care article, Mary Caffrey explores the use of technology and social media to engage patients for clinical trials and features Seeker Health and our CEO, Sandra Shpilberg.
Finding and recruiting the right patients into these clinical trials can be difficult, especially when it comes to rare diseases or uncommon disorders. In the past, companies leveraged radio ads, billboards, ads at bus stops among other techniques but as the world becomes more digital, these tactics have become more expensive and less effective. W20 Group sat down with CEO of Seeker Health, Sandra Shpilberg, to discuss how the company is leveraging digital marketing to recruit patients more effectively.
Sandra Shpilberg, CEO of Seeker Health, has interviewed many rare disease patients over time as part of her work helping drugmakers find participants for clinical trials. In a recent article, she argues that rare diseases patients, regardless of their particular ailment, share a common burden. This podcast discusses this burden and ways that stakeholders can collaborate for better patient outcomes.
Finding qualified clinical research subjects can be like finding the proverbial needle in the haystack. Until, that is, you find where the needled haystacks are. Sandra Shpilberg explains a successful approach.